Repository logo
 

The role of emergent champions in policy implementation for decentralised drug-resistant tuberculosis care in South Africa

dc.contributor.authorLe Roux, Sacha Roxanne
dc.contributor.authorJassat, Waasila
dc.contributor.authorDickson, Lindy
dc.contributor.authorMitrani, Leila
dc.contributor.authorCox, Helen
dc.contributor.authorMlisana, Koleka
dc.contributor.authorBlack, John
dc.contributor.authorLoveday, Marian
dc.contributor.authorGrant, Alison D
dc.contributor.authorMoshabela, Mosa
dc.contributor.authorKielmann, Karina
dc.contributor.authorNicol, Mark P
dc.date.accessioned2022-12-20T12:23:46Z
dc.date.available2022-12-20T12:23:46Z
dc.date.issued2022-12-09
dc.date.submitted2022-02-24
dc.date.updated2022-12-20T11:00:08Z
dc.descriptionFrom BMJ via Jisc Publications Router
dc.descriptionHistory: received 2022-02-24, accepted 2022-11-07, ppub 2022-12, epub 2022-12-09
dc.descriptionPeer reviewed: True
dc.descriptionAcknowledgements: This paper draws on data from a 4-year project that aimed to gain an understanding of the policy context, patient care pathways and models of decentralisation of DR-TB care in three South African provinces. The authors would like to thank and acknowledge Dr Norbert Ndjeka (SA NDOH), key informants, staff and participants interviewed and the provinces of the Western Cape, Eastern Cape, KwaZulu-Natal for all their time, critical insights and assistance.
dc.descriptionPublication status: Published
dc.descriptionFunder: Medical Research Council; FundRef: http://dx.doi.org/10.13039/501100000265; Grant(s): MR/N015924/1
dc.descriptionKarina Kielmann - ORCID: 0000-0001-5519-1658 https://orcid.org/0000-0001-5519-1658
dc.description.abstractObjective: Champions are recognised as important to driving organisational change in healthcare quality improvement initiatives in high-income settings. In low-income and middle-income countries with a high disease burden and constrained human resources, their role is highly relevant yet understudied. Within a broader study on policy implementation for decentralised drug-resistant tuberculosis care in South Africa, we characterised the role, strategies and organisational context of emergent policy champions. Design: Interviews with 34 healthcare workers in three South African provinces identified the presence of individuals who had a strong influence on driving policy implementation forward. Additional interviews were conducted with 13 participants who were either identified as champions in phase II or were healthcare workers in facilities in which the champions operated. Thematic analyses using a socio-ecological framework further explored their strategies and the factors enabling or obstructing their agency. Results: All champions occupied senior managerial posts and were accorded legitimacy and authority by their communities. ‘Disease-centred’ champions had a high level of clinical expertise and placed emphasis on clinical governance and clinical outcomes, while ‘patient-centred’ champions promoted pathways of care that would optimise patients’ recovery while minimising disruption in other spheres of their lives. Both types of champions displayed high levels of resourcefulness and flexibility to adapt strategies to the resource-constrained organisational context. Conclusion: Policymakers can learn from champions’ experiences regarding barriers and enablers to implementation to adapt policy. Research is needed to understand what factors can promote the sustainability of champion-led policy implementation, and to explore best management practices to support their initiatives.
dc.description.ispublishedpub
dc.description.statuspub
dc.identifierpublisher-id: bmjgh-2022-008907
dc.identifierdoi: 10.1136/bmjgh-2022-008907
dc.identifierhttps://eresearch.qmu.ac.uk/handle/20.500.12289/12713/12713.pdf
dc.identifier.citationLe Roux, S.R., Jassat, W., Dickson, L., Mitrani, L., Cox, H., Mlisana, K., Black, J., Loveday, M., Grant, A.D., Moshabela, M., Kielmann, K. and Nicol, M.P. (2022) ‘The role of emergent champions in policy implementation for decentralised drug-resistant tuberculosis care in South Africa’, BMJ Global Health, 7(12), p. e008907. Available at: https://doi.org/10.1136/bmjgh-2022-008907.
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/12713
dc.identifier.urihttps://doi.org/10.1136/bmjgh-2022-008907
dc.languageen
dc.publisherBMJ Publishing Group
dc.rightsLicence for this article starting on 2022-12-09: http://creativecommons.org/licenses/by-nc/4.0/
dc.rightsEmbargo: ends 2022-12-09
dc.rightsThis is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
dc.rights.licenseAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceeissn: 2059-7908
dc.subjectOriginal research
dc.subject1506
dc.subjectpublic health
dc.subjecttuberculosis
dc.subjectqualitative study
dc.titleThe role of emergent champions in policy implementation for decentralised drug-resistant tuberculosis care in South Africa
dc.typearticle
dcterms.accessRightspublicen
dcterms.dateAccepted2022-11-07
qmu.authorKielmann, Karina
refterms.dateAccepted2022-11-07
refterms.depositExceptionPublished Gold OA

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
12713.pdf
Size:
878.63 KB
Format:
Adobe Portable Document Format
Description: